Hematology/Oncology Clinical Studies

Through clinical trials, the Pediatric Hematology/Oncology team at Children's Hospital of Pittsburgh of UPMC is accelerating the search for cures to childhood cancer. Collaborating closely with the Children’s Oncology Group (COG), the only pediatric oncology clinical trials group funded by the National Cancer Institute and National Institutes of Health, Children’s is among an elite group hospitals participating in Phase I clinical trials through COG and the Pediatric Brain Tumor Consortium.

To help you locate a study relevant to your interests, we have organized them as follows: 

Brain and CNS Cancers Neuroblastomas
Leukemia Tumors/Non-Sarcoma
Lymphoma Tumors/Sarcoma
Rare Cancers and Blood Disorders

Simply select a category and then browse the studies within the category to review brief descriptions and requirements. Or if you are looking for a study dealing with a specific condition, please use the search tool at the top of this page. Be sure to include the word "study" along with the name of the condition. Physicians or parents/guardians of pediatric patients who might be eligible are encouraged to inquire about enrollment. Contact information is listed at the end of each study.

Phase I Cancer Studies
Clinical Trials follow a “staged” development process. Certain studies are indicated as “Pilot” or “Phase I” studies. These are among the most experimental clinical trials and should be considered after other treatments or trials have been attempted without success. Learn more about Phase I cancer studies

Thank you for exploring these opportunities and helping us to find cures and prevent childhood disease.

Last Update
February 3, 2015
  • Increase/Decrease Text Size
  • Print This Page
Last Update
February 3, 2015